スポンサーリンク
Department of Hospital Pharmacy, Nagasaki University School of Medicine | 論文
- Synthesis of Dibenzoylmethane Derivatives and Inhibition of Mutagenicity in Salmonella typhimurium
- IN VITRO OXIDATION OF THE 8-HYDROXYQUINOLINE MOIETY WITH METABOLIC ACTIVATION SYSTEM TO A MUTAGENIC QUINOLOQUINONE COMPOUND OF LAVENDAMYCIN ANALOGS
- ISOLATION AND CHARACTERIZATION OF A NEW 5-AMINOFURYLTHIAZOLE FROM THE CATALYTIC REDUCTION OF 4-(5-NITRO-2-FURYL) THIAZOLE
- In Vivo Microdialysis for the Transdermal Absorption of Valproate in Rats
- In Vivo Microdialysis for Pharmacokinetic Investigations : A Plasma Protein Binding Study of Valproate in Rabbits
- Effect of Sodium Valproate (VPA) on Cerebral Amino Acids : Mechanism of γ-Aminobutyric Acid (GABA) Elevation and Possible Causal Relation of VPA-Induced Encephalopathy and Glutamine Level
- Ocular Pharmacokinetic/Pharmacodynamic Modeling for Multiple Anti-glaucoma Drugs
- Influence of murine hepatitis induced by D-(+)-galactosamine hydrochloride and lipopolysaccharide on gene expression of polyethylenimine/plasmid DNA polyplex
- Ocular Pharmacokinetic/Pharmacodynamic Modeling for Timolol in Rabbits Using a Telemetry System
- Stomach-Selective Gene Transfer Following the Administration of Naked Plasmid DNA onto the Gastric Serosal Surface in Mice
- Partial Hepatectomy Enhances Polyethylenimine-Mediated Plasmid DNA Delivery
- Antimicrobial Activity of Saturated Fatty Acids and Fatty Amines against Methicillin-Resistant Staphylococcus aureus
- Sensitive and Real-Time Method for Evaluating Corneal Barrier Considering Tear Flow
- Fluorescence Microscopic Demonstration of Cathepsin K Activity as the Major Lysosomal Cysteine Proteinase in Osteoclasts
- In Vivo Ocular Pharmacokinetic Model for Designing Dosage Schedules and Formulations of Ophthalmic Drugs in Human
- Change in Erythrocyte Shape Induced by Cyclosporine Administration
- Acquisition of Drug Resistance to Imipenem and Other Newer Beta-Lactams by Pseudomonas aeruginosa
- Acquisition of Resistance to Beta-Lactams by Enterobacter cloacae and Serratia marcescens in the Clinical Field
- Acquisition of Resistance to Beta-Lactams by Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens
- Differences in Effects of Oncogenes on Sensitivity to Anticancer Drugs